Introduction:The impact of albumin resuscitation on sepsis outcomes is debated, particularly in the initial phase of resuscitation. We aimed to investigate the association between albumin use in the initial 6h of resuscitation and subsequent outcomes in adult septic patients.Methods:This single-center, retrospective, propensity score-matched cohort study included adult patients admitted to intensive care units (ICUs) with sepsis or septic shock from January 1, 2006, to May 4, 2018, at a tertiary referral hospital. We compared two groups based on albumin receipt within the initial six resuscitation hours (albumin group vs. non-albumin group). We performed a 1:2 propensity score matching to assess shock-free time in ICU as the primary outcome.Results:Of 2,732 patients with medical sepsis, 286 cases in the albumin group were matched with 549 individuals in the non-albumin group. Compared to the non-albumin group, the albumin group required more intravenous fluids and had higher net fluid balance, lower mean arterial pressure, and lower serum base excess level in the initial 6 and 24h of resuscitation. Shock-free time, ICU and hospital length of stay, and 28-day mortality were not different between albumin and non-albumin groups (56 vs. 66h, P=0.18; 3.5days vs. 3.7days, P=0.61; 9.1days vs. 9.5days, P=0.27; 36% vs. 32%, P=0.25, respectively).Conclusions:Using albumin during the initial 6h of resuscitation was not associated with benefits in clinical outcomes of patients with medical sepsis.
- septic shock
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine
- Emergency Medicine